Relationship between blood type and outcomes following COVID-19 infection

• Type of Material: Article
• Authors: Young Kim, Harvard Medical School; Christopher A. Latz, Harvard Medical School; Charles S. DeCarlo, Harvard Medical School; Sujin Lee, Emory University; C. Y. Maximilian Png, Harvard Medical School; Pavel Kibrik, New York University; Eric Sung, Harvard Medical School; Olamide Alabi, Emory University; Anahita Dua, Harvard Medical School
• Language: English
• Date: 2021-10-09
• Publisher: W B SAUNDERS CO-ELSEVIER INC
• Publication Version: Final Published Version
• Copyright Statement: © 2021 Elsevier Inc. All rights reserved.
• Final Published Version (URL): http://dx.doi.org/10.1053/j.semvascsurg.2021.05.005
• Title of Journal or Parent Work: SEMINARS IN VASCULAR SURGERY
• Volume: 34
• Issue: 3
• Start Page: 125
• End Page: 131
• Keywords: RISK; SUSCEPTIBILITY; Science & Technology; Cardiovascular System & Cardiology; Life Sciences & Biomedicine; Surgery; Peripheral Vascular Disease
• Research Categories: Biology, Virology; Health Sciences, Medicine and Surgery

Abstract

Since the onset of the COVID-19 pandemic, a concentrated research effort has been undertaken to elucidate risk factors underlying viral infection, severe illness, and death. Recent studies have investigated the association between blood type and COVID-19 infection. This article aims to comprehensively review current literature and better understand the impact of blood type on viral susceptibility and outcomes.